Saint-Gobain adds high purity option to Sani-Tech line

Published: 24-Jan-2012
Manufacturing

Ultra-HP combines reinforced outer jacket with fully bonded FEP liner

Saint-Gobain has added the Sani-Tech Ultra-HP high purity hose to its Sani-Tech line of fluid transfer products.

Ultra-HP combines a tough outer jacket and hose comprising multiple layers of Sani-Tech Ultra platinum-cured silicone and 316L stainless steel helical wire reinforcement with a PharmaFluor FEP liner. The liner's smooth inner bore surface provides both optimal flow and ease of cleaning and sanitisation.

The PharmaFluor FEP liner is said to minimise bonding of biological materials and maintains fluid purity due to low TOCs, extractables and leachables. The liner is fully bonded to the silicone hose using a patented bonding technology, which helps ensure a high purity fluid path.

The company says the hose's overall light weight, low force to bend and exceptional flexibility make it suitable for a variety of applications, including bioprocessing, load cells, product transfer and steam-in-place/clean-in-place (SIP/CIP).

Sani-Tech Ultra-HP hose is made from USP Class VI compliant materials and certified to meet USP <88>, USP <87>, EP 3.1.9, ISO 10993, FDA 21 CFR 177.2600 and FDA 21 CFR 177.1550 requirements.

See more

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

Read more
French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
  3. UK REACH reform falls short as industry warns of £500m+ compliance bill The UK chemicals industry has condemned the Government's long-awaited response to the UK REACH Alternative Transitional Registration model consultation, arguing it does little to support growth or innovation
  4. Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
  5. Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Design & Build

Saint-Gobain completes Florida stage of global manufacturing expansion

French manufacturer is spending $77.5m on a global component manufacturing expansion programme spanning seven sites
Manufacturing

Saint-Gobain Performance Plastics acquires Applied Bioprocess Containers

Taking advantage of its expertise in the design and manufacture of bioprocess containers
Manufacturing

Saint-Gobain Sani-Tech Ultra tubing delivers improved performance

Saint-Gobain Performance Plastics in the US has added Sani-Tech Ultra platinum-cured silicone tubing to its portfolio
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now